Nardostachys jatamansi DC Extract Alleviates Insulin Resistance and Regulates Glucose Metabolism in C57BL/KsJ-db/db Mice Through the AMP-Activated Protein Kinase Signaling Pathway

다국어 초록 (Multilingual Abstract)

This study investigated whether Nardostachys jatamansi DC extract (NJE) improved insulin sensitivity and suppressed hepatic glucose production in an animal model of type 2 diabetes. C57BL/KsJ-db/db mice were divided into three dietary groups: regular diet (control), NJE, and rosiglitazone. After 6 weeks of feeding, blood glucose, glycosylated hemoglobin, and plasma insulin levels were significantly lower in NJE than in diabetic control group mice. The oral glucose tolerance test also revealed a positive effect of NJE on increasing insulin sensitivity. The homeostatic index of insulin resistance was significantly lower in NJE than in diabetic control group mice. NJE markedly lowered the plasma lipid concentration compared to diabetic control group mice. In the skeletal muscle, the expression of phosphorylated AMP-activated protein kinase, pAkt substrate of 160 kDa, and plasma membrane glucose transporter type 4 increased more in NJE compared to diabetic control group mice. NJE also decreased the expression of glucose-6-phosphatase and phosphoenolpyruvate carboxykinase in the liver. These findings demonstrate that NJE alleviates hyperglycemia by improving insulin sensitivity and inhibiting gluconeogenesis in the liver.

참고문헌 (Reference)

1 백설, "감송향의 in vitro 항산화 및 항염증 효과" 한의병리학회 23 (23): 853-859, 2009

2 민들레, "甘松香 (감송향)이 아토피樣 (양) 피부염에 미치는 영향" 대한한방소아과학회 26 (26): 13-24, 2012

3 Chatterji A, "The treatise on Indian medicinal plants;National Institute of Science Communication, Vol. 5" 99-100, 1997

4 Klip A, "The many ways to regulate glucose transporter 4" 34 : 481-487, 2009

5 Bechmann LP, "The interaction of hepatic lipid and glucose metabolism in liver diseases" 56 : 952-964, 2012

6 Haffner SM, "The homeostasis model in the San Antonio heartstudy" 20 : 1087-1092, 1997

7 Lyle N, "Stress modulating antioxidant effect of Nardostachys jatamansi" 46 : 93-98, 2009

8 Hulcher FH, "Simplified spectrophotometric assay for microsomal 3-hydroxy-3-methylglutaryl CoA reductase by measurement of coenzyme A" 14 : 625-631, 1973

9 Klip A, "Recruitment of GLUT-4 glucose transporters by insulin in diabetic rat skeletal muscle" 172 : 728-736, 1990

10 Babujanarthanam R, "Quercitrin, a bioflavonoid improves glucose homeostasis in streptozotocininduced diabetic tissues by altering glycolytic and gluconeogenic enzymes" 24 : 357-364, 2010

11 Katz A, "Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans" 85 : 2402-2410, 2000

12 Dragan S, "Polyphenols-rich natural products for treatment of diabetes" 22 : 14-22, 2015

13 Sato T, "Plasma membrane content of insulin-regulated glucose transporter in skeletal muscle of the male Otsuka Long-Evans Tokushima Fatty rat, a model of noninsulin-dependent diabetes mellitus" 407 : 329-332, 1997

14 Abdul-Ghani MA, "Pathogenesis of insulin resistance in skeletal muscle" 2010 : 476279-, 2010

15 Raptis SA, "Oral hypoglycemic agents: Insulin secretagogues, alpha-glucosidase inhibitors and inuslin sensitizers" 109 : 265-287, 2001

16 Arora RB, "Nardostachys jatamansi: A chemical, pharmacological and clinical appraisal" 51 : 1-117, 1965

17 Bae GS, "Nardostachys jatamansi protects against cerulean-induced acute pancreatitis" 39 : 520-529, 2010

18 Gagnon J, "Metformin directly inhibits ghrelin secretion through AMP-activated protein kinase in rat primary gastric cells" 15 : 276-279, 2013

19 Nyenwe EA, "Management of type 2 diabetes: Evolving strategies for the treatment of patients with type 2 diabetes" 60 : 1-23, 2011

20 Bagchi A, "Jatamols A and B: Sesquiterpenoids of Nardostachys jatamansi roots 1" 57 : 282-283, 1991

21 Sano H, "Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation" 278 : 14599-14602, 2003

22 Klip A, "Insulin-induced translocation of glucose transporters in rat hindlimb muscles" 224 : 224-230, 1987

23 Bonora E, "Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity" 23 : 57-63, 2000

24 Guo X, "Glycolysis in the control of blood glucose homeostasis" 2 : 358-367, 2012

25 Agius L, "Glucokinase and molecular aspects of liver glycogen metabolism" 414 : 1-18, 2008

26 Shaw JE, "Global estimates of the prevalence of diabetes for 2010 and 2030" 87 : 4-14, 2010

27 Park SA, "Genistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/db mice" 79 : 1207-1213, 2006

28 Alhassane T, "Flaxseed lignans: Source, biosynthesis, metabolism, antioxidant activity, bio-active components and health benefits" 9 : 261-269, 2010

29 Rui L, "Energy metabolism in the liver" 4 : 177-197, 2014

30 Osorio-Fuentealba C, "Electrical stimuli release ATP to increase GLUT4 translocation and glucose uptake via $PI3K{\gamma}$-Akt-AS160 in skeletal muscle cells" 62 : 1519-1526, 2013

31 Jung UJ, "Effects of the ethanol extract of the roots of Brassica rapa on glucose and lipid metabolism in C57BL/KsJ-db/db mice" 27 : 158-167, 2008

32 Fonseca V, "Effect of thiazolidinediones on body weight in patients with diabetes mellitus" 115 : 42-48, 2003

33 Larsen ML, "Effect of long-term monitoring of glycosylated hemoglobin levels in insulindependent diabetes mellitus" 323 : 1021-1025, 1990

34 Robinson C, "Effect of insulin on glycerol production in obese adolescents" 274 : 737-743, 1998

35 Sharon FS, "Dietary zinc supplementation attenuates hyperglycemia in db/db mice" 226 : 43-51, 2001

36 Taskinen MR, "Diabetic dyslipidaemia: From basic research to clinical practice" 46 : 733-749, 2003

37 Hrebicek J, "Detection of insulin resistance by simple quantitative insulin senstivitiy check index QUICKI for epidemiological assessment and prevention" 87 : 144-147, 2002

38 Muniyappa R, "Current approaches for assessing insulin sensitivity and resistance in vivo: Advantages, limitations, and appropriate usage" 294 : 15-26, 2008

39 Czoski-Murray C, "Clinical effectiveness and cost-effectiveness of pioglitazone and rosiglitazone in the treatment of type 2 diabetes: A systematic review and economic evaluation" 8 : 1-91, 2004

40 Fujiwara T, "Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats" 37 : 1549-1558, 1988

41 Kwak CS, "Cell fractionation method of the rat liver" 5 : 45-53, 1986

42 Cerf ME, "Beta cell dysfunction and insulin resistance" 4 : 1-12, 2013

43 Hollander P, "Anti-diabetes and anti-obesitymedications: Effects on weight in people with diabetes" 20 : 159-165, 2007